Eikon Therapeutics
Grzegorz Nawrocki is a seasoned scientist specializing in computational chemistry and biological physics, currently serving as a Senior Scientist at Eikon Therapeutics since June 2024. Previous experience includes a role as Staff Scientist at NeoTX Therapeutics LTD, focusing on the design and optimization of drug candidates, and at INTERX, INC., where technology development was key. Grzegorz's academic background encompasses a Master's degree in Biophysics from Jagiellonian University and a PhD in Biological Physics from the Polish Academy of Sciences, alongside significant research as a Postdoctoral Scientist at Michigan State University, where modeling proteins and studying their interactions were primary responsibilities.
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.